PRIME THERAPEUTICS for PRIME THERAPEUTICS
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
H.R. 1204 Community Pharmacy Fairness Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY STEFFL | — |
Health Issues HCR
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY STEFFL | — |
Medicare/Medicaid MMM
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act Regulatory provisions related to Medicare Part D. Provisions included in health reform proposals that would impact Part D, such as formulary requirements, anti-kickback statutes for generic drug copay waivers, Medicaid rebate changes, direct negotiation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY STEFFL | — |
Insurance INS
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY STEFFL | — |
Pharmacy PHA
S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Provisions related to settlement payments between manufacturers to delay introduction of generic pharmaceutical products Benefit design and coverage of pharmaceutical benefits in health and PBM disclosure in health reform proposals Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY STEFFL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.